[Clinical short-term outcome of brachytherapy for the treatment of choroidal metastasis].

Abstract

OBJECTIVE:

To observe and evaluate the therapeutic effect of brachytherapy for choroidal metastasis.

METHODS:

A restrospective case-series study. The data of 22 patients with 23 eyes of choroidal metastasis undergoing ruthenium 106 radioactive applicator brachytherapy were retrospectively analyzed from the Eye Center of People Hospital of Peking University from Feb. 2004 and Sep. 2012. Ocular tumor control, globe salvage rate and the visual acuity of the patients were observed and analyzed.

RESULTS:

Eighteen patients of 18 eyes were followed up. The median age of the 18 patients was 59 years and the median time of follow-up was 13 months. The remission of tumors with decreasing of subretinal fluid volume were obviously achieved and the globes were all reserved. At follow-up, 13 patients' visual acuity was above or equal to 0.3, one patient's visual acuity was under 0.05, 4 patients' visual acuity was between 0.05 and 0.3.

CONCLUSION:

Brachytherapy was an effective option for the treatment of choroidal metastasis.

• Authors: Lili Guo, Jianhong Liang, Xiaoxin Li
• Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology (Zhonghua Yan Ke Za Zhi) Vol. 50 Issue 10 Pg. 743-6 (Oct 2014) ISSN: 0412-4081 [Print] China
• PMID: 25547576 (Publication Type: Journal Article)

Chemical References

• Ruthenium Radioisotopes

Topics

• Aged
• Brachytherapy
• Choroid Neoplasms (radiotherapy, secondary)
• Humans
• Middle Aged
• Remission Induction
• Retrospective Studies
• Ruthenium Radioisotopes (therapeutic use)
• Visual Acuity